Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|January 17, 2012
Modulation of GITR for cancer immunotherapyDavid A Schaer, Judith T Murphy, Jedd D Wolchok
Journal for Immunotherapy of Cancer|May 24, 2014
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapyDavid A Schaer, Daniel Hirschhorn-Cymerman, Jedd D Wolchok
Current Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
Anti-GITR antibodies--potential clinical applications for tumor immunotherapyDavid A Schaer, Adam D Cohen, Jedd D Wolchok
The Journal of Experimental Medicine|September 28, 2011
Hiding the road signs that lead to tumor immunityDavid A Schaer, Alexander M Lesokhin, Jedd D Wolchok
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2013
Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor typesPaolo A Ascierto, Michael Kalos, David A Schaer, et al.
Cancer Immunology Research|January 14, 2014
GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stabilityDavid A Schaer, Sadna Budhu, Cailian Liu, et al.
Mabs|June 29, 2018
FcγRIIIa-dependent IFN-γ release in whole blood assay is predictive of therapeutic IgG1 antibodies safetyNada S Alakhras, Jiabin Qiu, Guilherme V Rocha, et al.
Pageof 2